Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Cancer researchers investigate free radicals

The University of Leicester has been selected as the hub of a worldwide network of researchers to investigate one of the causes of cancer.

11 Oct 2007

African-American men have a slightly higher risk of PSA recurrence

African-American men are more likely to have their prostate cancer return after treatment, but their disease is no more aggressive when it does recur than that of their white counterparts, according to a study led by Duke Prostate Center researchers.

10 Oct 2007

HAART stops brain damage caused by HIV

A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the October 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

9 Oct 2007

What our genes tell us - Identifying biomarkers for key environmental risk factors

Identifying biomarkers for the key environmental risk factors responsible for two diseases that significantly contribute to death and disease of hundreds of thousands annually will be the initial focus of a new center being established at Pacific Northwest National Laboratory.

4 Oct 2007

Ovarian Cancer Biomarker Research Act of 2007 introduced

The Ovarian Cancer Biomarker Research Act of 2007 was introduced in the U.S. House of Representatives on Thursday, Sept. 27 and the Society of Gynecologic Oncologists (SGO), the leader of four organizations integral in drafting this legislation, is issuing a "call to action" for ovarian cancer survivors, their families, and their physicians.

3 Oct 2007

Defining biomarkers for better colon cancer treatment

Barcelona, Spain: New research has yielded a clearer picture of which biomarkers could help doctors more precisely target the treatment of colon cancer, bringing closer the day when patients who will not benefit from chemotherapy are spared it, while those that will, get the more aggressive treatment they need.

27 Sep 2007

Sandia develops portable microfluidic platform to detect biotoxins

Of all the threat scenarios facing emergency responders around the country, the release and spread of a dangerous biotoxin in a large public space is one of the most troubling.

27 Sep 2007

A blood test for concussions - aim of new research

The University of Rochester Medical Center received $1.5 million to develop a blood test for concussions by isolating proteins that can predict memory loss, chronic headaches or other neurological problems.

26 Sep 2007

Discovery of two new proteins associated with colorectal cancer

Researchers at the Zhejiang University, Hangzhou have discovered that mimecan and Thioredoxin Domain-Containing Protein 5 (TXNDC5) were differentially expressed in colorectal adenoma.

25 Sep 2007

Prana completes enrolment in phase IIa trial of PBT2 in Alzheimer's disease patients

Prana Biotechnology Limited today announced it has completed patient enrollment in its Phase IIa clinical trial of PBT2 in patients with early Alzheimer's disease.

24 Sep 2007

Past clinical trials of vitamin E fatally flawed

Generations of studies on vitamin E may be largely meaningless, scientists say, because new research has demonstrated that the levels of this micronutrient necessary to reduce oxidative stress are far higher than those that have been commonly used in clinical trials.

24 Sep 2007

Growth hormone does not improve physical performance

Anyone who injects growth hormone with the intention of gaining muscle mass and improving performance should think again.

24 Sep 2007

Framingham Heart Study 100K result published

BioMed Central has announced that 17 research articles carried out using genetic data from the Framingham Heart Study (FHS), are being published as a supplement to BMC Medical Genetics.

23 Sep 2007

Process of necrosis redefined in landmark study

A new study led by investigators from the University of Pittsburgh School of Medicine demonstrates that the process of necrosis, long thought to be a chaotic, irreversible pathway to cell death, may actually be triggered as part of a regulated response to stress by a powerful protein, SRP-6, that can potentially halt necrosis in its path.

21 Sep 2007

Genes for osteoporosis

Researchers at Hebrew SeniorLife's Institute for Aging Research (IFAR) have examined close to 100,000 genetic markers for low bone mass and aging to help determine which genes are responsible for the development of osteoporosis and longevity.

21 Sep 2007

Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits

Researchers from Boston University School of Medicine (BUSM), Boston University School of Public Health (BUSPH), and the National Heart, Lung and Blood Institute (NHLBI), have completed analyses of a genome-wide scan on a group of two generations of participants from the landmark Framingham Heart Study (FHS).

20 Sep 2007